Privia Health stock reports strong Q2 growth and guidance

Published on 10/01/2026 at 00:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Privia Health stock posted Q2 revenue of USD 632.63 million, up 21.40 percent year over year. Fiscal 2026 guidance targets the high end of USD 2.35 billion to USD 2.45 billion.

PRVA, US74283G1004, Illustration mit AI erstellt.

Privia Health (ISIN US74283G1004) delivered Q2 2026 revenue of USD 632.63 million, up 21.40 percent year over year, while adjusted EPS reached USD 0.19 versus USD 0.07 consensus, according to MarketBeat on September 25, 2026. The figures give the healthcare platform a clear operating anchor as investors assess its fiscal 2026 outlook.

Revenue growth beats expectations

MarketBeat reported that quarterly revenue exceeded the USD 597.33 million consensus estimate by USD 35.30 million. The 21.40 percent year-over-year increase also contrasted with adjusted EPS of USD 0.24 in the comparable quarter, making the earnings comparison more demanding despite the estimate beat.

The same report said 11 of 14 analysts rated the stock a buy and three recommended holding it. The consensus 12-month price target was USD 31.00, while Canaccord Genuity Group set a USD 32.00 target in an August 7, 2026 report cited by MarketBeat.

Guidance reaches the high end

For fiscal 2026, Privia Health expects revenue between USD 2.35 billion and USD 2.45 billion and is targeting the high end of that range, as reported by The Globe and Mail. The company generated Q2 net profit of USD 9.05 million, compared with USD 2.69 million in the year-earlier quarter, according to the same report.

That guidance matters because the latest quarterly revenue of USD 632.63 million annualizes to a scale that is already close to the lower end of the full-year range. The comparison is directional rather than a forecast, since Privia reports quarterly revenue and guidance on different measurement bases.

Network scale supports the platform

Privia Health says its platform serves more than 5,600 providers across more than 1,300 practice locations and reaches more than 6.1 million patients. Its investor-relations page also lists practice collections above USD 3.47 billion, linking the operating network to a substantial flow of healthcare activity through the platform.

The company describes its model as a combination of technology, population-health tools, practice management and value-based care services. That mix helps explain why provider scale and practice collections are important alongside revenue and earnings.

Next earnings date is November 5

DFV Terminal lists November 5, 2026 as the next earnings date. The scheduled report will give investors a fresh test of the USD 2.35 billion to USD 2.45 billion fiscal 2026 revenue range.

Market capitalization is USD 2.5 billion

Privia Health had a market capitalization of USD 2.5 billion as of September 30, 2026. Its 52-week range was USD 18.92 to USD 28.82 as of September 25, 2026, placing the latest reported opening level of USD 19.39 close to the lower end of that interval.